Dark

SNGX
Soligenix, Inc. Common Stock
stock NASDAQ

At Close

Dec 26, 2025 3:59:59 PM EST

1.38USD-3.819%(-0.06)227,971

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 26, 2025 9:17:30 AM EST

1.40USD-2.778%(-0.04)6,464

After-hours

Dec 26, 2025 4:28:30 PM EST

1.37USD-1.083%(-0.01)1,300

OverviewHistoricalExchangesShortsNews

Jan 12, 2022

12:01PM EST Soligenix Says Is Still On Track To File NDA For HyBryte In Latter Half Of 2022 Benzinga

Jan 10, 2022

07:47AM EST Soligenix Provides Corporate Update Letter Benzinga

07:31AM EST Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts PR Newswire

Jan 6, 2022

07:31AM EST Soligenix to Present at Upcoming Investor Conferences PR Newswire

Jan 4, 2022

07:46AM EST Soligenix: Dusquetide Effective At Reducing Tumor Size In RTTNews

07:38AM EST Soligenix : Dusquetide Shows Positive Anti-tumor Efficacy In Multiple Nonclinical Animal Studies; Stock Up RTTNews

07:31AM EST Soligenix Highlights Studies On Efficacy Of Dusquetide Benzinga

07:31AM EST Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical PR Newswire

Dec 23, 2021

04:08PM EST Soligenix 8-K Shows Co. Received Notice From Nasdaq Co. Not In Compliance With $1/Share Minimum Bid Price Requirement; Co. Has Til Jun. 20, 2022 To Regain Compliance Benzinga

Dec 2, 2021

07:34AM EST Soligenix Announces Successful Protection Using A Bivalent Thermostabilized Filovirus Vaccine Benzinga

07:31AM EST Soligenix Announces Successful Protection using a Bivalent Thermostabilized PR Newswire

Nov 12, 2021

07:45AM EST Soligenix Q3 EPS $(0.09) Down From $(0.06) YoY, Sales $200.00K Down From $600.00K YoY Benzinga

07:35AM EST Soligenix Q3 Revenues $0.2 Mln Vs. $0.6 Mln Prior Year RTTNews

07:31AM EST Soligenix Announces Recent Accomplishments And Third Quarter 2021 Financial PR Newswire

Nov 8, 2021

07:33AM EST Soligenix Granted Pediatric Investigational Plan Waiver For HyBryte In CTCL In United Kingdom RTTNews

07:31AM EST Soligenix Granted Pediatric Investigational Plan Waiver for HyBryte(tm) in CTCL PR Newswire

Nov 4, 2021

07:31AM EDT Soligenix Announces Publication Demonstrating Enduring Protection of its PR Newswire

Nov 2, 2021

10:24AM EDT Soligenix To File US Application For Its Lymphoma Photodynamic Therapy In 2H 2022 Benzinga

Nov 1, 2021

07:31AM EDT Soligenix Says Thermostable Vaccine Technology Platform To Be Presented At 6th International Conference On Vaccines Research And Development Benzinga

07:31AM EDT Thermostable Vaccine Technology Platform to be Presented at the 6th PR Newswire

Oct 29, 2021

04:14PM EDT Soligenix Says Unable To Provide Pre-Requisite Amount Of Accrued Stability Data Required To File Its Hybryte NDA With FDA By First Half Of 2022; Says Timeline For Anticipated NDA Filing With FDA Is Being Adjusted To H2 2022 Benzinga

06:14AM EDT The following are some of the stocks making big moves in Friday's pre-market trading (as of 05.45 A.M. EDT). RTTNews

Oct 18, 2021

07:34AM EDT The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs Benzinga

Oct 12, 2021

07:31AM EDT the National Organization for Rare Disorders' Rare Diseases and Orphan Products Breakthrough Summit PR Newswire

Oct 11, 2021

06:08AM EDT The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.55 A.M. EDT). RTTNews

Sep 29, 2021

12:31PM EDT SNGX: CiVax Shows Protective Effects Against SARS-CoV-2 Variant in Non-Human Primates Benzinga

12:18PM EDT Soligenix Shares See Volume; Hearing Zacks Sets $6 Price Target Benzinga

Sep 28, 2021

07:40AM EDT Soligenix Announces Efficacy And Broad Neutralizing Activity Of Its COVID-19 Vaccine CiVax In Non-Human Primates RTTNews

07:33AM EDT Soligenix Highlights Publication Demonstrating 'Efficacy and Broad Neutralizing Activity' Of Its COVID-19 Vaccine In Non-Human Primates Benzinga

07:31AM EDT Soligenix Announces Accelerated Publication Demonstrating Efficacy and Broad PR Newswire

Sep 27, 2021

07:40AM EDT Soligenix Invited To Present At The Cantor Fitzgerald Global Healthcare Conference Benzinga

07:31AM EDT Soligenix Invited to Present at the Cantor Fitzgerald Global Healthcare PR Newswire

Sep 16, 2021

01:15PM EDT Soligenix To Test Synthetic Hypericin In Psoriasis Patients Benzinga

01:14PM EDT Soligenix To Synthetic Hypericin In Psoriasis Patients Benzinga

08:23AM EDT Soligenix to Advance Synthetic Hypericin Development in Psoriasis PR Newswire

Sep 9, 2021

08:25AM EDT Soligenix, Inc. (SNGX) said the Office of Orphan Products Development of FDA has granted orphan drug designation to the active ingredient hypericin for the treatment of T-cell lymphoma, extending the target population beyond cutaneous T-cell lymphoma. RTTNews

07:34AM EDT Soligenix: FDA Grants Orphan Drug Designation For Treatment Of T-cell Lymphoma RTTNews

07:31AM EDT FDA Grants Soligenix Orphan Drug Designation For The Treatment Of T-Cell Lymphoma Benzinga

07:31AM EDT FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell PR Newswire

Sep 3, 2021

06:24AM EDT Soligenix on Thursday Received FDA Orphan Drug Designation for Hypericin for Treatment of T-cell lymphoma Benzinga

Aug 24, 2021

08:31AM EDT Soligenix: Developing Tools to Tackle the Next Potential Pandemic; PCG Digital PR Newswire

Aug 23, 2021

07:37AM EDT Soligenix Reports Publication Showing Formulation, Heat Stabilization Of Filovirus Vaccine Platform For Ebola RTTNews

07:34AM EDT Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases Benzinga

07:33AM EDT Soligenix Highlights Publication Demonstrating Successful Formulation And Heat Stabilization Of Filovirus Vaccine Platform For Ebola And Marburg Virus Diseases Benzinga

07:31AM EDT Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases PR Newswire

Aug 18, 2021

09:52AM EDT Soligenix Reports Positive Preclinical Data With Filovirus RTTNews

08:55AM EDT Soligenix Announces Positive Preclinical Data With Multiple Heat Stable Filovirus Vaccine Candidates; Stock Surges RTTNews

08:53AM EDT Soligenix Announces Preclinical Data With Multiple Heat Stable Filovirus Vaccine Candidates Benzinga

08:53AM EDT Soligenix Announces Positive Preclinical Data with Multiple Heat Stable PR Newswire

Aug 13, 2021

04:20PM EDT Soligenix Files Prospectus Supplement Related to Offering Of $30M Of Common Stock Benzinga

07:36AM EDT Soligenix Q2 Revenues Decline To $0.2 Mln From $0.5 Mln Prior Year RTTNews

07:32AM EDT Soligenix Q2 EPS $(0.05) Up From $(0.10) YoY Benzinga

07:31AM EDT Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial PR Newswire

Jul 6, 2021

03:44PM EDT Soligenix To Develop And Move Toward Potential Commercialization Of Hybryte As A Novel First In Class Photodynamic Therapy Utilizing Safe Visible Light For The Treatment Of Early Stage CTCL Benzinga

03:39PM EDT via NewMediaWire --PCG Digital -- A rare form of non-Hodgkins lymphoma, cutaneous T-cell lymphoma (CTCL) has no current FDA-approved first-line therapies. There are roughly 3,000 new CTCL cases in the United States each year, with more than 20,000 patients living with CTCL. GlobeNewswire Inc

Jun 22, 2021

08:10AM EDT Soligenix Shares Up Pre Market Following Earlier Co. Press Release Highlighting Pivotal Phase 3 FLASH Study Selected For Presentation At US Cutaneous Lymphoma Consortium Annual Meeting Jun. 26 Benzinga

07:45AM EDT HyBryte Says Positive Pivotal Phase 3 FLASH Study Selected For Presentation At USCLC Annual Meeting RTTNews

07:31AM EDT HyBryte(tm) Positive Pivotal Phase 3 FLASH Study Selected for Presentation at PR Newswire

Jun 10, 2021

07:33AM EDT Soligenix Gets Pediatric Investigational Plan Waiver From EMA For HyBryte In Cutaneous T-cell Lymphoma RTTNews

07:32AM EDT Soligenix Receives Pediatric Investigational Plan Waiver For HyBryte In CTCL From European Medicines Agency Benzinga

07:30AM EDT Soligenix Receives Pediatric Investigational Plan Waiver for HyBryte(tm) in PR Newswire

Jun 9, 2021

07:35AM EDT Soligenix Receives $865,000 In Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program Benzinga

07:31AM EDT Soligenix Receives $865,000 in Non-Dilutive Funding Through New Jersey PR Newswire

May 20, 2021

07:41AM EDT Soligenix Gets Japanese Patent For Improved Production Of Synthetic Hypericin Composition RTTNews

07:33AM EDT Soligenix Receives Japanese Patent For Improved Production Of Synthetic Hypericin Composition Benzinga

07:31AM EDT Soligenix Receives Japanese Patent for Improved Production of Synthetic PR Newswire

May 17, 2021

07:39AM EDT Soligenix Q1 EPS $(0.06) Up From $(0.32) YoY, Sales $100.00K Down From $900.00K YoY Benzinga

07:35AM EDT Soligenix Q1 Net Loss $2.4 Mln Or $0.06/shr Vs. Net Loss $7.6 Mln Or $0.32/shr Last Year RTTNews

07:31AM EDT Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial PR Newswire

May 14, 2021

07:59AM EDT The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts Benzinga

May 13, 2021

08:10AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use Benzinga

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 10, 2021

08:39AM EDT Soligenix Stock Plummets After It Announces Not To Pursue Rolling US Application Submission For HyBryte Benzinga

07:30AM EDT HyBryte(tm) Awarded Innovation Passport in the United Kingdom PR Newswire

May 4, 2021

07:31AM EDT Broad Efficacy and Improved Safety Profile of HyBryte(tm) Presented at Society PR Newswire

Apr 28, 2021

07:31AM EDT Soligenix Presents at the National Foundation for Infectious Diseases Annual PR Newswire

Apr 26, 2021

07:26AM EDT Soligenix Presents HyBryte Expanded Efficacy And Safety Data At American Academy Of Dermatology Meeting RTTNews

07:09AM EDT Soligenix Highlights Presentation Of HyBryte Expanded Efficacy And Safety Data Presented At American Academy of Dermatology Meeting Benzinga

07:01AM EDT HyBryte(tm) Expanded Efficacy and Safety Data Presented at the American Academy PR Newswire

Apr 23, 2021

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 13, 2021

07:01AM EDT Soligenix Announces Presentations at Prominent Scientific Conferences PR Newswire

Apr 7, 2021

07:12AM EDT Soligenix Gets Conditional FDA Acceptance Of Proposed Brand Name HyBryte For SGX301 In CTCL RTTNews

07:01AM EDT Soligenix Receives Conditional FDA Acceptance Of Proposed Brand Name HyBryte For SGX301 In CTCL Benzinga

07:01AM EDT Soligenix Receives Conditional FDA Acceptance of Proposed Brand Name PR Newswire

Mar 30, 2021

07:15AM EDT Soligenix FY Basic Net Loss $17.7 Mln Or $0.64/Shr Vs Loss $9.4 Mln Or $0.48/Shr Last Year RTTNews

07:04AM EDT Soligenix Announces FY20 EPS $(0.64), Down From $(0.48) YoY Benzinga

07:01AM EDT Soligenix Announces Recent Accomplishments And Year-End 2020 Financial Results PR Newswire

Mar 9, 2021

09:16AM EST Soligenix To Receive $865,000 In Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program Benzinga

07:01AM EST Soligenix to Receive $865,000 in Non-Dilutive Funding Through New Jersey PR Newswire

Mar 4, 2021

08:12AM EST The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company Benzinga

07:22AM EST Soligenix Shares Rally On Positive Preclinical Data For COVID-19 Vaccine Candidate Benzinga

07:17AM EST Soligenix Announces Positive Progress In Pre-clinical Development Of COVID-19 Vaccine RTTNews

07:06AM EST Soligenix Highlights Publication Of Pre-Clinical Studies For The CiVax COVID-19 Vaccine Program Benzinga

07:01AM EST Soligenix Announces Positive Progress in the Pre-clinical Development of its PR Newswire

Feb 24, 2021

07:08AM EST Soligenix Issues Shareholder Letter, Highlights Upcoming Catalysts Benzinga

07:01AM EST Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate PR Newswire

Feb 11, 2021

07:01AM EST Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference PR Newswire

Feb 1, 2021

07:06AM EST Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma Benzinga

07:01AM EST Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin PR Newswire

Jan 25, 2021

08:38AM EST Soligenix Last Week Announced Will Host Investor Webcast Event On Tuesday, Jan. 26, 2021 From 2:30-4 p.m. EST Related To US Conmmercial Planning For SGX301 In Treatment Of Cutaneous T-Cell Lymphoma Benzinga

08:37AM EST CORRECTION: Soligenix Announced Will Host Webcast Event On Jan. 26 On Tuesday Of Last Week Benzinga

08:36AM EST Soligenix Shares Spike To Pre-Market High Following Press Release From Investor Relations Firm, PCG Digital, Highlighting Upcoming Webcast, Recent Data From Phase 3 FLASH Trial Of SGX301 Candidate For Cutaneous T-Cell Lymphoma Benzinga

08:33AM EST Soligenix To Host Investor Webcast Event On Tuesday, Jan. 26, 2021 From 2:30-4 p.m. EST Related To US Conmmercial Planning For SGX301 In Treatment Of Cutaneous T-Cell Lymphoma Benzinga

Jan 19, 2021

07:01AM EST Soligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in PR Newswire

Jan 7, 2021

07:19AM EST Soligenix Inks Deal With Daavlin For Supply Of SGX301 Companion Light Device In Cutaneous T-Cell Lymphoma RTTNews

07:17AM EST Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma Benzinga

07:01AM EST Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma PR Newswire

Jan 1, 2021

01:43AM EST SNGX: Phase 3 Trial of SGX942 Does Not Meet Primary Benzinga

Dec 28, 2020

07:07AM EST Soligenix Reports $1.5 Mln NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development RTTNews

07:01AM EST Soligenix Reports $1.5M National Institutes Of Health Small Business Innovation Research Award Advancing COVID-19 Vaccine Benzinga

07:00AM EST Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award PR Newswire

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 22, 2020

02:32PM EST Mid-Afternoon Market Update: Dow Falls 120 Points; Soligenix Shares Plummet Benzinga

01:00PM EST Mid-Day Market Update: Crude Oil Down 1.8%; Ocugen Shares Spike Higher Benzinga

10:27AM EST Mid-Morning Market Update: Markets Mixed; CarMax Profit Tops Expectations Benzinga

07:45AM EST The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes Benzinga

06:48AM EST Soligenix: Phase 3 Trial Of SGX942 Fails To Achieve RTTNews

06:35AM EST Soligenix Phase 3 DOM-INNATE Study Fails To Meet Primary Endpoint Of Median Duration RTTNews

06:33AM EST Soligenix Announces Topline Results From Phase 3 Clinical Trial Of SGX942; Primary Endpoint Of Median Duration Of SOM Did Not Achieve The Pre-Specified Criterion For Statistical Significance Benzinga

06:30AM EST Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 PR Newswire

Dec 16, 2020

09:22AM EST Soligenix Entersa $20 Mln Convertible Debt Financing Agreement RTTNews

09:10AM EST Soligenix Announces $20M Strategic Convertible Debt Financing Agreement With Pontifax Medison Debt Financing Benzinga

09:03AM EST Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement PR Newswire

Dec 9, 2020

08:32AM EST Soligenix Says COVID-19 Vaccine Candidate, CiVax, Could Be 'More Viable Alternative' To Moderna, Pfizer Benzinga

Dec 8, 2020

08:16AM EST Soligenix Shows Extended Protection With Its RiVax Ricin Toxin Vaccine RTTNews

08:01AM EST Soligenix Demonstrates Extended Protection with its RiVax(r) Ricin Toxin Vaccine PR Newswire

Dec 4, 2020

06:36AM EST B. Riley FBR Initiates Coverage On Soligenix with Buy Rating, Announces Price Target of $4 Benzinga

Nov 12, 2020

07:34AM EST Soligenix Q3 Net Loss $1.8 Mln Or $0.06/shr Vs. Net Loss $2.7 Mln Or $0.14/shr Last Year RTTNews

07:02AM EST Soligenix Q3 EPS $(0.06) Up From $(0.14) YoY, Sales $600.00K Down From $1.30M YoY Benzinga

07:01AM EST Soligenix Announces Recent Accomplishments And Third Quarter 2020 Financial PR Newswire

Nov 10, 2020

07:01AM EST Soligenix Invited to Present at Upcoming Virtual Investor Conferences PR Newswire

Oct 22, 2020

10:40AM EDT Why Soligenix's Stock Is Trading Higher Today Benzinga

09:08AM EDT Soligenix : Phase 3 FLASH Study Continues To Show Positive Benefits In Patients With Cutaneous T-Cell Lymphoma RTTNews

09:05AM EDT Soligenix Reports Phase 3 FLASH Study Continues To Show Benefits In Patients With Cutaneous T-Cell Lymphoma Benzinga

09:02AM EDT Soligenix Announces Phase 3 FLASH Study Continues to Demonstrate Positive PR Newswire

Oct 8, 2020

09:41AM EDT Soligenix to Present at the BIO Investor Forum PR Newswire

Sep 15, 2020

08:01AM EDT Soligenix Reports Publication Demonstrating Thermostabilization Of Filovirus Vaccine Antigens RTTNews

07:32AM EDT Soligenix Highlights Publication Demonstrating Thermostabilization Of Filovirus Vaccine Antigens Benzinga

07:31AM EDT Soligenix Announces Publication Demonstrating Thermostabilization of Filovirus PR Newswire

Sep 10, 2020

07:34AM EDT Soligenix Announces Investor Webcast Event And Presentation Today Titled 'Advantages of the CiVax Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine' Benzinga

Sep 9, 2020

07:01AM EDT Soligenix Invited to Present at Upcoming Virtual Investor Conferences PR Newswire

Sep 3, 2020

07:30AM EDT Soligenix Announces Investor Webcast Event: Advantages of the CiVax(tm) Program PR Newswire

Aug 27, 2020

07:01AM EDT Soligenix to Present at the LD Micro Conference PR Newswire

Aug 14, 2020

08:26AM EDT The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal Benzinga

07:08AM EDT Soligenix Q2 Net Loss $2.8 Mln Or $0.10/Shr Vs Loss $2.1 Mln Or $0.12/Shr Last Year RTTNews

07:03AM EDT Soligenix Q2 EPS $(0.10) Up From $(0.12) YoY, Sales $500.00K Down From $1.40M YoY Benzinga

07:01AM EDT Soligenix Announces Recent Accomplishments And Second Quarter 2020 Financial PR Newswire

Jul 28, 2020

11:17AM EDT Dawson James Downgrades Soligenix to Neutral, Lowers Price Target to $2 Benzinga

07:54AM EDT Benzinga Pro's Top 5 Stocks To Watch For Tues., Jul. 28, 2020: MCD, AAPL, SBUX, SNGX, GWPH Benzinga

07:23AM EDT Soligenix Unveils Publication Of Positive Pre-clinical Results For Novel COVID-19 Vaccine RTTNews

07:08AM EDT Soligenix Highlights Publication Of Pre-Clinical Results Of Novel Coronavirus Vaccine: Rapid Immune Responses Showed With CoVaccine HT Adjuvant In Prototype Vaccine, Saw Neutralizing Antibodies, Th1 Antibody, Cell Mediated Responses Established Benzinga

07:01AM EDT Soligenix Announces Publication of Positive Pre-clinical Results for a Novel PR Newswire

Jul 20, 2020

07:09AM EDT Soligenix Says Phase 3 Clinical Program Timelines Remain On Track, Expects Top-Line Results for its SGX942 in Q4 2020 Benzinga

07:01AM EDT Soligenix Issues Corporate Update - Highlights Important Catalysts for Second PR Newswire

Jul 17, 2020

04:56PM EDT Soligenix Inc Files For Mixed Shelf Offering of Up to $50M Benzinga